According to the information in the TCGA database, FABP5 was expressed higher in the ccRCC tumors compared with the native tissues; the patients with higher FABP5 expression also exhibited a low survival rate (Figure 3G,H). This evidence concerns the gene FABP5 and nonpapillary renal cell carcinoma.